If You鈥檙e Poor, Fertility Treatment Can Be Out of Reach
For low-income people who are on Medicaid or whose employer health plan is skimpy, help for infertility seems unattainable.
The independent source for health policy research, polling, and news.
41 - 60 of 227 Results
For low-income people who are on Medicaid or whose employer health plan is skimpy, help for infertility seems unattainable.
Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.
The law, which takes effect Jan. 1, prohibits out-of-network ground ambulance operators from billing patients more than they would pay for in-network rides. It also caps how much the uninsured must pay.
Chances are, if you aren鈥檛 older, chronically ill, or obese, you don鈥檛 need a forthcoming covid vaccine to stay out of the hospital. But it probably wouldn鈥檛 hurt.
Medicare was supposed to cover the entire cost of his procedure. But after the anesthesia provider failed to file its claims in a timely manner, it billed the patient instead.
Although nearly 40% of Americans 60 and older are obese, Medicare doesn鈥檛 cover weight loss medications. Meanwhile, studies haven鈥檛 thoroughly examined new drugs鈥 impact on older adults.
The Food and Drug Administration鈥檚 approval is viewed as groundbreaking, but many details still must be figured out.
The state now requires Medicaid to cover midwife services and has expanded the list of prescription drugs midwives can administer.
Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court鈥檚 ruling could have major implications for determining a 鈥渞easonable price鈥 in health care.
Eli Lilly's news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
Colorado鈥檚 proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
KHN gives readers a chance to comment on a recent batch of stories.
Another effort to make upfront cost comparisons possible in an industry known for its opaqueness: an online tool for consumers to get some idea of what they may pay for medical care.
Coal mining ended in Germany鈥檚 Saarland a decade ago, but the transition away from coal has been smoother than in West Virginia, which has more medical debt than any state in America.
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.
State employees could receive checks ranging from $50 to thousands of dollars if they choose the right provider.
As private equity groups are swarming into aging America鈥檚 eye care, the consolidation is costing the U.S. health care system and patients more money.
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
漏 2026 麻豆女优